You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India
|
|---|---|
| Published in |
Malaria Journal, March 2012
|
| DOI | 10.1186/1475-2875-11-97 |
| Pubmed ID | |
| Authors |
Anupkumar R Anvikar, Bhawna Sharma, Bhartendu H Shahi, Prajesh K Tyagi, Tarit K Bose, Surya K Sharma, Prakriti Srivastava, Bina Srivastava, Jean R Kiechel, Aditya P Dash, Neena Valecha |
| Abstract |
Artemisinin-based combination therapy (ACT) has been recommended for the treatment of falciparum malaria by the World Health Organization. Though India has already switched to ACT for treating falciparum malaria, there is need to have multiple options of alternative forms of ACT. A randomized trial was conducted to assess the safety and efficacy of the fixed dose combination of artesunate-amodiaquine (ASAQ) and amodiaquine (AQ) for the treatment of uncomplicated falciparum malaria for the first time in India. The study sites are located in malaria-endemic, chloroquine-resistant areas. |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 4% |
| Colombia | 1 | 1% |
| France | 1 | 1% |
| Indonesia | 1 | 1% |
| Australia | 1 | 1% |
| Belgium | 1 | 1% |
| Unknown | 77 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 22% |
| Student > Master | 14 | 16% |
| Student > Ph. D. Student | 10 | 12% |
| Other | 9 | 11% |
| Student > Doctoral Student | 6 | 7% |
| Other | 14 | 16% |
| Unknown | 13 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 25% |
| Agricultural and Biological Sciences | 14 | 16% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Social Sciences | 4 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
| Other | 17 | 20% |
| Unknown | 20 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2016.
All research outputs
#5,167,056
of 24,400,706 outputs
Outputs from Malaria Journal
#1,363
of 5,827 outputs
Outputs of similar age
#32,942
of 164,201 outputs
Outputs of similar age from Malaria Journal
#14
of 69 outputs
Altmetric has tracked 24,400,706 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,827 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,201 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.